Allergan Inc. should put any acquisition it might strike in the coming weeks to a shareholder vote, proxy advisory firm Institutional Shareholder Services said in a report critical of the company's handling of a hostile bid.
WSJ.com: What's News US, Wall Street Journal: Home US
Wed, 10/01/2014 - 8:09am
Allergan Inc. should put any acquisition it might strike in the coming weeks to a shareholder vote, proxy advisory firm Institutional Shareholder Services said in a report critical of the company's handling of a hostile bid.